These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Arachidonic acid promotes FAK activation and migration in MDA-MB-231 breast cancer cells. Navarro-Tito N, Robledo T, Salazar EP. Exp Cell Res; 2008 Nov 01; 314(18):3340-55. PubMed ID: 18804105 [Abstract] [Full Text] [Related]
3. Oleic acid promotes migration on MDA-MB-231 breast cancer cells through an arachidonic acid-dependent pathway. Navarro-Tito N, Soto-Guzman A, Castro-Sanchez L, Martinez-Orozco R, Salazar EP. Int J Biochem Cell Biol; 2010 Feb 01; 42(2):306-17. PubMed ID: 19931412 [Abstract] [Full Text] [Related]
5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar 01; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
7. Neutrophil granulocytes promote the migratory activity of MDA-MB-468 human breast carcinoma cells via ICAM-1. Strell C, Lang K, Niggemann B, Zaenker KS, Entschladen F. Exp Cell Res; 2010 Jan 01; 316(1):138-48. PubMed ID: 19747913 [Abstract] [Full Text] [Related]
9. Benzo-[a]-pyrene induces FAK activation and cell migration in MDA-MB-231 breast cancer cells. Castillo-Sanchez R, Villegas-Comonfort S, Galindo-Hernandez O, Gomez R, Salazar EP. Cell Biol Toxicol; 2013 Aug 01; 29(4):303-19. PubMed ID: 23955088 [Abstract] [Full Text] [Related]
10. Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells. Castro-Sanchez L, Soto-Guzman A, Navarro-Tito N, Martinez-Orozco R, Salazar EP. Eur J Cell Biol; 2010 Nov 01; 89(11):843-52. PubMed ID: 20709424 [Abstract] [Full Text] [Related]
11. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity. Kim HP, Lee MS, Yu J, Park JA, Jong HS, Kim TY, Lee JW, Bang YJ. Biochem J; 2004 Apr 01; 379(Pt 1):141-50. PubMed ID: 14720123 [Abstract] [Full Text] [Related]
15. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway. Chen LC, Tu SH, Huang CS, Chen CS, Ho CT, Lin HW, Lee CH, Chang HW, Chang CH, Wu CH, Lee WS, Ho YS. Breast Cancer Res Treat; 2012 Aug 01; 134(3):989-1004. PubMed ID: 22434522 [Abstract] [Full Text] [Related]
16. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo. Ma JG, Huang H, Chen SM, Chen Y, Xin XL, Lin LP, Ding J, Liu H, Meng LH. Breast Cancer Res Treat; 2011 Nov 01; 130(1):85-96. PubMed ID: 21181437 [Abstract] [Full Text] [Related]
17. Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells. Bocca C, Bozzo F, Martinasso G, Canuto RA, Miglietta A. Br J Nutr; 2008 Oct 01; 100(4):739-50. PubMed ID: 18304389 [Abstract] [Full Text] [Related]